Akademisyen profili · PROFESÖR
DİDEM ŞENER DEDE
ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
25
Q2
33
Q3
18
Q4
5
WoS (JCR)
Q1
11
Q2
18
Q3
24
Q4
28
TR Index
8
makale
Makaleler
- 2025 The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer
- 2025 Large Unstained Cells: A Predictive Biomarker for Recurrence and Survival in Resected Gastric Cancer
- 2025 Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer
- 2025 Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancer
- 2025 Synergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study
- 2025 Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis
- 2025 Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer
- 2025 The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Treatment
- 2024 A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review.
- 2024 Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer
- 2024 Akciğer Kanserinde Epidemiyoloji, Tanı ve Evreleme
- 2023 Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations
- 2023 Do metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?
- 2023 Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data
- 2023 Should clinical trials about prostate cancer assess the frailty as an endpoint?
- 2022 Efficacy and safety of folfiri plus aflibercept in second‑line treatment of metastatic colorectal cancer: Real‑life data from Turkish oncology group
- 2022 Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
- 2021 Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
- 2021 The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
- 2021 Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients